Biocon Ltd. NSE: BIOCON | BSE: 532523

Strong Performer, Getting Expensive

Download real time

394.45 -0.20 (-0.05%)

New 52W High in past week

3.0M

NSE+BSE Volume

NSE 17 Jul, 2025 12:50 PM (IST)

US FDA Approval

Biocon gets US FDA approval for Kirsty insulin drug with annual sales of $1.9 billion See details

Biocon Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Biocon Ltd. from all sources in a single place.

Load latest

Is Biocon Ltd. worth buying?

721 Votes:

Buy 75.03%

Sell 16.23%

Hold 8.74%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >